Ann: MLA Quarterly Update March 2017, page-3

Agree Spartacus.

It’s really pleasing to see Tuta growing strongly again at a rate of 9.6%. It will need to keep growing like this if the company is to offset the loss of CareFusion in FY2018.

The Tuta business achieving the same sales as the December quarter is noteworthy and a fantastic achievement. Traditionally December is strong as hospitals order up ahead of the break with January being very weak.

There is a lot of potential with Clements, but it remains a WIP.

In rough terms Tuta accounts for 70% of MLA sales and Clements 10% - i.e. Tuta dominates the sales. These two companies have a long history and it’s interesting to note that once upon a time this was somewhat reversed. At its peak Clements did $60M in sales per annum and Tuta did $30M per annum.

We can only dream of such sales figures like these now!

References
Clements sales: http://adb.anu.edu.au/biography/clements-hubert-ingham-12846
Tata sales: http://www.medaust.com/irm/PDF/1036_0/ResultsofGeneralMeeting   (section 2.2)